View
7
Download
0
Category
Preview:
Citation preview
194
REFERENCES
1. Fauci AS, Kasper DL, Braunwald E, Hauser SL, Longo DL, Jameson JL,
Loscalzo J, editors. Harrrison’s Principles of Internal Medicine. 17th Edition.
New York. McGraw Hills; 2008. Available at: http://www.accessmedicine.co
2. Mohiuddin SF. The Diabetes Epidemic in India. [Jan 21, 2012] available at:
http://diabeteshealth.com/read/2012/01/21/7423/the-diabetes-epidemic-in-
india--/
3. King, Hilary. 1998. Conference proceedings. IX National Congress of
Diabetes, Mumbai.
4. Kokiwar PR, Gupta S, Durge PM. Prevalence of diabetes in a rural area of
central India. Int J Diab Dev Ctries. 2007;27(1):8-10.
5. care.diabetesjournals.org Standards of Medical Care in Diabetes- 2012.
Diabetes Care. 2012;35:S11-S63.
6. Kumar V, Abbas A K , Fausto N, editors. Robbins and Cotran Pathologic
Basis of Disease. 7th Edition. Pennsyl vania. Noordanesh Medical Publication
(Elsevier Saunders); 2005.
7. Brownlee M. Biochemistry and molecular cell biology of diabetic
complications. NATURE.2001;414:813-820.
8. Zelmanovitz T, Gerchman F, Balthazar A P S, Thomazelli F C S, Matos J D,
Canani L H. Diabetic nephropathy. Diabetology & Metabolic Syndrome.
2009;1:10 doi:10.1186/1758-5996-1-10.
9. Teoh SL, Latiff A ABD, Das S. Histological changes in the kidneys of
experimental diabetic rats fed with Momordica charantia (bitter gourd) extract.
Romanian Journal of Morphology and Embryology 2010;51(1):91–95.
10. Sima A A F, Nathaniel V, Bril V, Mcewen T A J Greene D A.
Histopathological Heterogeneity of Neuropathy in Insulin-dependent and Non
insulin-dependent Diabetes, and Demonstration of Axo-glial Dysjunction in
Human Diabetic Neuropathy J. Clin.Invest.1988;81:349-364.
11. Schalkwijk CG, Stehouwer C D A. Vascular complications in diabetes
mellitus: the role of endothelial dysfunction. Clinical Science. 2005;109:143–
159.
195
12. The Diabetes Control and Complications Trial Research Group. The effect of
intensive treatment of diabetes on the development and progression of long-
term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med.
1993;329:977–986.
13. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose
control with sulphonylureas or insulin compared with conventional treatment
and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet
1998;352:837–853.
14. McPhee SJ, Papadakis MA, Tierney LM, editors. CURRENT Medical
Diagnosis & Treatment. Mc Graw Hill, LANGE; 2008.
15. Kar A, Choudhary BK, Bandyopadhyay NG. Comparative evaluation of
hypoglycemic activity of some Indian medicinal plants in alloxan diabetic rats.
J Ethnopharmacol.2003; 84(1):105-108.
16. Mukherjee P K, Maiti K, Mukherjee K, Houghton P J. Leads from Indian
medicinal plants with hypoglycemic potentials. J. Ethnopharmacol.
2006;106(1):1-28.
17. Chattopadhyay RR. A comparative evaluation of some blood sugar lowering
agents of plant origin. J Ethnopharmacol.1999;67:367-372.
18. Tripathi A K., Bhoyar P K, Baheti J R, Biyani D M, Khalique M, Kothmire M
S, Amgaonkar Y M, Bhanarkar A B. Herbal Antidiabetics: A Review. Int. J.
Res. Pharm. Sci. 2011;2(1):30-37.
19. Birdee G S, Yeh G. Complementary and Alternative Medicine Therapies for
Diabetes: A Clinical Review. Clinical Diabetes. 2010;28(4):147-155.
20. Shojaii A, Goushegir A, Dabaghian F H, Abdollahi M, Huseini H F. Herbs
and herbal preparations for glycemic control in diabetes mellitus (a systematic
review). Journal of Medicinal Plants Research. 2011; 5(16):3846-3855.
Available online at http://www.academicjournals.org/JMPR
21. Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam T P A. Indian Herbs
and Herbal Drugs Used for the Treatment of Diabetes. J. Clin. Biochem. Nutr.
2007;40:163–173.
22. Alarcon-Aguilar F J, Roman-Ramos R, Flores-Saenz J L, Aguirre-Garci F.
Investigation on the hypoglycemic effects of four Mexican medicinal plants
in normal and alloxan diabetic mice. Phytother Res. 2002;16(4):383-386.
196
23. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian medicinal plants.
Council of Scientific and Industrial Research. New Delhi.1956.
24. Kumar B D, Mitra A, Manjunatha M. In vitro and in vivo studies of
antidiabetic Indian medicinal plants: A Review. Journal of Herbal Medicine
and Toxicology. 2009;3(2):9-14.
25. Kamble SM, Kamlakar PL,Vaidya S,Bambole VD. Influence of Coccinia indica
on certain enzymes in glycolytic and lipolytic pathway in human diabetics. Ind J
Med Sci.1998;54(4):143-6.
26. Eldin I M T, Ahmed E M, Abd Elwahab H.M. Preliminary study of the
clinical Hypoglycemic effects of Allium cepa (Red Onion) in Type 1 and Type
2 Diabetic patients. Environmental Health Insights 2010;4 :71–77.
27. Leatherdale BA, Panesar RK, Singh G, Afkina TW, Bailley CJ, Bignell AH.
Improvement in glucose tolerance due to Momordica Charantia (Karela). Brit
Med J. (clinical research edition)1981;282(6279):1823-1824.
28. Sharma RD, Raghuram TC, Rao NS. Effect of fenugreek seeds on blood
glucose and serum lipids in Type 1 diabetes. Eur J Clin Nutr 1990;44(4):301-
306.
29. Yoshikawa M, Nishida H, Takada M, KawharaY, Matsuda H. Polyphenol
constituents from Salacia species. Quantitative analysis of mangiferin with α –
glucosidase and aldose reductase inhibitory activities. Yakuguku Zasshi.
2001;121:371-378.
30. Lee H S. Rat lens aldose reductase inhibitory activities of Coptis japonica root
derived isoquinoline alkaloids. J Agri Food Chem. 2002;50(24):7013-7016.
31. Halder N, Joshi S, Gupta SK. Lens aldose reductase inhibitory potential of
some indigenous plants. J Ethnopharmacol. 2003;86:113-116.
32. Ortiz-Andrade RR, Garcia-Jimenez S, Castillo-Espana P, Ramirez-Avila G,
Vilalobos-Molina R, Estrada-Soto S. α- Glucosidase inhibitory activity of the
methanolic extract from Tournefotia hartwegiana: An anti-hyperglycemic
agent. J Ethnopharmacol. 2007;109(1):48-53.
33. Ivorra MD, Paya M, Villar A. Hypoglycemic and insulin release effect of
tormentic acid: a new hypoglycemic natural product. Planta Medica.
1988;54:282-286.
34. Marles RJ, Farnsworth NR. Antidiabetic plants and their active constituents.
Phytomedicine. 1995;2(2):137-189.
197
35. Kar A, Choudhary BK, Bandyopadhyay NG. Preliminary studies on the
inorganic constituents of some hypoglycemic herbs on oral glucose tolerance
test. J Ethnopharmacol.1999;64(2):179-184.
36. Scartezzini P, Speroni E. Review on some plants of Indian traditional
medicine with antioxidant activity. J Ethnopharmacol. 2000;71: 23–43.
Available online at: www.elsevier.com:locate:jethpharm
37. Masuda T, Toi Y, Bando H, Mackawa T, Takeda Y, Yamaguchi H. Structural
identification of new curcumin dimmers and their contribution to the
antioxidant mechanism of curcumin. J Agri Food Chem. 2002;50(9):2524-
2530.
38. Leu TH, Maa MC. The molecular mechanisms for the antitumorigenic effect
of curcumin. Curr Med Chem Anti-Canc.Agents.2002;2:357-370.
39. Atangwho IJ, Ebong PE, Eyong EU, Williams IO, Eteng MU, Egbung GE.
Comparative chemical composition of leaves of some antidiabetic medicinal
plants: Azadirachta indica, Vernonia amygdalina and Gongronema latifolium.
African Journal of Biotechnology. 2009;8(18):4685-4689. Available online at
http://www.academicjournals.org/AJB
40. Dahanukar SA, Kulkarni RA, Rege NN. Pharmacology of medicinal plants
and natural products. Indian Journal of Pharmacology 2000;32:S81-S118.
41. Saneja A, Sharma C, Aneja K R, Pahwa R. Gymnema Sylvestre (Gurmar): A
Review. Der Pharmacia Lettre 2010;2(1):275-284.
42. WarreN RP, WarreN RM, Weninger MG. Inhibition of the Sweet Taste
by Gymnema sylvestre. Nature.1969;223:94 –95.
43. Gent J F, Hettinger T P, Frank M E, Marks L E. Taste confusions following
Gymnemic Acid Rinse. Chem Senses. 1999;24: 393-403.
44. Shore LE. A contribution to our knowledge of taste sensations. From the
Physiological Laboratory, Cambridge.191-217.
45. Shanmugasundaram ER, Gopinath KL, Shanmugasundaram KR, Rajendran V
M. Possible regeneration of the islets of langerhans in streptozotocin-diabetic
rats given Gymnema sylvestre leaf extracts. J
Ethnopharmacol.1990;30(3):265-279.
198
46. Shanmugasundaram E R B, Rajeswar G, Baskaran K, Kumar B R R,
Shanmugasundaram K R, Ahmath B K.Use of gymnema sylvestre leaf extract
in the control of blood glucose in insulin-dependent diabetes mellitus. J
Ethnopharmacol.1990;30:281- 294.
47. Okabayashi Y, Tani S, Fujisawa T, Koide M, Hasegawa H, Nakamura T,
Fujii M, Otsuki M. Effect of Gymnema sylvestre, R.Br. on glucose
homeostasis in rats. Diabetes Res Clin Pract. 1990;9(2):143-148.
48. Baskaran K, Kizar Ahmath B, Radha Shanmugasundaram K,
Shanmugasundaram ER. Antidiabetic effect of a leaf extract from Gymnema
sylvestre in non-insulin-dependent diabetes mellitus patients. J
Ethnopharmacol. 1990;30:295-305.
49. Persaud SJ, Al-Majed H, Raman A, Jones PM. Gymnema sylvestre stimulates
insulin release in vitro by increased membrane permeability. J
Endocrinol.1999;163(2):207-212.
50. Kamei K, Takano R, Miyasaka A, Imoto T, Hara S. Amino acid sequence of
sweet-taste-suppressing peptide (gurmarin) from the leaves of Gymnema
sylvestre. J Biochem. 1992;111:109-12.
51. Liu H M, Kiuchi F, Tsuda Y. Isolation and structural elucidation of
Gymnemic acids, antisweet principles of Gymnema sylvestre. Chem. Pharm.
Bull. 1992;40(6):1366-1375.
52. Yoshikawa M, Murakami T, Kadoya M, Li Y, Murakami N, Yamahara J,
Matsuda H. Medicinal Foodstuffs. IX.1) The Inhibitors of Glucose Absorption
from the Leaves of Gymnema sylvestre R.BR. (Asclepiadaceae): Structure of
Gymnemosides a and b. Chem.Pharm.Bull.1997;45(10):1671-1676.
53. Yoshikawa M, Murakami T, Matsuda H. Medicinal Foodstuffs. X.1) Structure
of New Triterpene Glycosides, Gymnemosides-c,-d, -e, and –f, from the
Leaves of Gymnema sylvestre R. Br.: Influence of Gymnema Glycosides on
Glucose Uptake in Rat Small Intestinal Fragments.
Chem.Pharm.Bull.1997;45(12):2034-2038.
54. Chowdhary F, Rasool M H. Isolation and characterization of Gymnemic acid
from Indigenous Gymnema sylvestre. J App Pharm.2010;3(2):60-65.
55. Shanmugasundaram KR, Pannerselvam C, Samudram P, Shanmugasundaram
ER. Enzyme changes and glucose utilization in diabetic rabbits: the effect of
Gymnema sylvestre, R.Br. J Ethnopharmacol.1983;7(2):205-234.
199
56. Prakash AO, Mathur S, Mathur R. Effect of feeding gymnema sylvestre leaves
on blood glucose in beryllium nitrate treated rats.
J.Ethnopharmacol.1986;18:143-146.
57. Srivatsava Y, Bhatt H V, Jhala CI .Oral Gymnema sylvestre R.Br. leaf
extracts inducing protracted longevity and hypoglycemia in alloxan diabetic
rats: Review and experimental study. Int J Crude Drug Res.1986;24:171-176.
58. Shanmugasundaram ERB, Venkatasubrahmanyam M, Vijendran N,
Shanmugasundaram K R. Effect of isolate from Gymnema sylvestre R.Br. in
the control of diabetes mellitus and the associated pathological changes.
Ancient Science of Life. 1988;7:183-194.
59. Shimizu K, Iino A, Nakajima J, Tanaka K, Nakajyo S, Urakawa N, Atsuchi M,
Wada T, Yamashita C. Suppression of glucose absorption by some fractions
extracted by Gymnema sylvestre leaves. J Vet Med Sci. 1997;59(4):245-251.
60. Chattopadhyay RR. Possible mechanism of antihyperglycemic effect of
Gymnema sylvestre leaf extract, part I. Gen.Pharmacol.1998;31:495-496.
61. Galletto R, Siqueira V L D, Ferreira E B, Oliveira A J B, Bazotte R B.
Absence of Antidiabetic and Hypolipidemic Effect of Gymnema sylvestre in
Non-diabetic and Alloxan-Diabetic Rats. Brazilian Archives of Biology and
Technology. 2004;47(4):545-551.
62. Gholap S, Kar A. Gymnemic acids from Gymnema sylvestre. Potentially
regulates dexamethasone-induced hyperglycemia in mice. Pharmaceutical
Biology.2005;43:192-195.
63. Sujin R M, Subin R M, Mahesh R, Mary R V J. Anti-Diabetic Effect of
Gymnema sylvestre (Asclepiadaceae) Powder in the Stomach of Rats.
Ethnobotanical Leaflets 2008;12:1158-1167.
64. Liu B, Asare-Anane H, Al-Romaiyan A, Huang G C, Amiel S A, Jones P M,
Persaud S J. Characterization of the insulinotropic activity of an aqueous
extract of Gymnema sylvestre in mouse β –cells and human islets of
langerhans. Cell.Physiol.Biochem.2009;23:125-132.
65. Mall G K, Mishra P K , Prakash V. Antidiabetic and Hypolipidemic Activity
of Gymnema sylvestre in Alloxan Induced Diabetic Rats. Global Journal of
Biotechnology & Biochemistry 2009;4(1):37-42.
200
66. Bishayee A, Chatterjee M. Hypolipidaemic and antiatherosclerotic effects of
oral Gymnema sylvestre R.Br. leaf extract in albino rats fed on a high fat diet.
Phytotherapy Research. 1994;8(2):118-120.
67. Nakamura Y, Tsumura Y, Tonogai Y, Shibata T. Fecal steroid excretion is
increased in rats by oral administration of Gymnemic acids contained in
Gymnema sylvestre leaves. J. Nutrition. 1999;129:1214-1222.
68. Shigematsu N, Asano R, Shimosaka M, Okazaki M. Effect of Administration
with the Extract of Gymnema sylvestre R.Br Leaves on Lipid Metabolism in
Rats. Biol.Pharm.Bull. 2001;24(6):713-717.
69. Shigematsu N, Asano R, Shimosaka M, Okazaki M. Effect of Long Term-
Administration with Gymnema sylvestre R.Br on Plasma and Liver Lipid in
Rats. Biol.Pharm.Bull. 2001;24(6):643-649.
70. Preuss HG, Bagchi D, Bagchi M, Rao C V S, Dey D K., Satyanarayana S.
Effects of a natural extract of (–)-hydroxycitric acid (HCA-SX) and a
combination of HCA-SX plus niacin-bound chromium and Gymnema
sylvestre extract on weight loss. Diabetes, Obesity and Metabolism,
2004;6:171–180.
71. Gloria YY, David ME, Ted JK, Russell SP. Systematic review of herbs and
dietary supplements for glycemic control in diabetes. Diabetes Care.
2003;26(4):1277-1294.
72. Matthew JL. Gymnema sylvestre for diabetes mellitus: A Systematic Review.
The J of Alternative and Complementary Medicine. 2007;13(9):977-983.
73. Kanetkar P, Singhal R, Kamat M. Gymnema sylvestre: A Memoir.
J.Clin.Biochem.Nutr.2007;41:77-81.
74. Ogawa Y, Sekita K, Umemura T, Saito M, Ono A, Kawasaki Y, Uchida O,
MatsushimaY, Inoue T, Kanno J. Gymnema sylvestre leaf extract: a 52-week
dietary toxicity study in Wistar rats. Shokuhin Eiseigaku Zasshi. 2004;45(1):8-
18.
75. Fushiki T, Kojima A, ImotoT, Inoue K, SugimotoE. An Extract of Gymnema
sylvestre Leaves and Purified Gymnemic Acid Inhibits Glucose-Stimulated
Gastric Inhibitory Peptide Secretion in Rats. J. Nutr. 1992;122:2367-2373.
201
76. Preuss H G, Jarrell S T, Scheckenbach R, Lieberman S, Anderson R A.
Comparative Effects of Chromium, Vanadium and Gymnema Sylvestre on
Sugar-Induced Blood Pressure Elevations in SHR. Journal of the American
College of Nutrition. 1998;17(2):116–123.
77. Katsukawa H, Imoto T, Ninomiya Y. Induction of Salivary gurmarin-binding
proteins in rats fed Gymnema-containing diets. Chem. Senses.1999;24:387-
392.
78. Harada S, Kasahara Y. Inhibitory effect of gurmarin on palatal taste responses
to amino acids in the rat. Am J Physiol Regulatory Integrative Comp Physiol.
2000;278(6):R1513-R1517.
79. Devi B P, Ramasubramaniaraja R. Pharmacognostical and Antimicrobial
screening of Gymnema sylvestre R.Br, and evaluation of Gurmar herbal tooth
paste and powder, composed of Gymnema sylvestre R.Br, extracts in dental
caries. International Journal of Pharma and Bio Sciences. 2010;1(3) :1-16.
80. Trivedi P D, Pundarikakshudu K, Shah K. A Validated Reverse Phase Liquid
Chromatographic Method for Quantification of Gymnemagenin in the
Gymnema Sylvestre R. Br. Leaf Samples, Extract and Market Formulation.
Int. J. Appl. Sci. Eng. 2011;9(1):25-31.
81. Augusti KT, Joseph P, Babu TD. Biologically active principles isolated from
Salacia oblonga Wall. Indian J Physiol Pharmacol 1995;39(4):415-417.
82. Ismail TS, Gopalakrishnan S, Begum VH, Elango V. Anti-inflammatory
activity of Salacia oblonga Wall. and Azima tetracantha Lam. J
Ethnopharmacol. 1997;56(2):145-152.
83. Krishnakumar K, Augusti KT, Vijayammal PL. Hypoglycemic and anti-
oxidant activity of Salacia oblonga Wall. extract in streptozotocin-induced
diabetic rats. Indian J Physiol Pharmacol.1999;43(4):510-514. (abstract)
84. Matsuda H, Murakami T, Yashiro K, Yamahara J, Yoshikawa M. Antidiabetic
principles of natural medicines. IV. Aldose reductase and alpha-glucosidase
inhibitors from the roots of Salacia oblonga Wall. (Celastraceae): structure of
a new friedelane-type triterpene, kotalagenin 16-acetate. Chem Pharm
Bull.1999;47(12):1725-1729.
85. Krishnakumar K, Augusti KT, Vijayammal PL. Anti-Peroxidative and
hypoglycemic activity of Salacia oblonga extract in diabetic rats.
Pharmaceutical Biology.2000;38(2):101-105.
202
86. Wolf BW, Weisbrode SE. Safety evaluation of an extract from Salacia
oblonga. Food Chem Toxicol. 2003;41(6):867-874.
87. Li Y, Peng G, Li Q, Wen S, Huang T H W, Roufogalis B D, Yamahara J.
Salacia oblonga improves cardiac fibrosis and inhibits postprandial
hyperglycemia in obese Zucker rats. Life Sci. 2004;75:1735-1746. Available
online at:www.sciencedirect.com
88. Collene AL, Hertzler SR, Williams JA, Wolf BW. Effects of a nutritional
supplement containing Salacia oblonga extract on postprandial glycemia,
insulinemia, and breath hydrogen responses in healthy adults. Nutrition.
2005;21:848-854.
89. Heacock PM, Hertzler SR, Williams JA, Wolf BW. Effects of a medical food
containing an herbal alpha-glucosidase inhibitor on postprandial glycemia and
insulinemia in healthy adults. J Am Diet Assoc.2005;105(8):65-71.
90. Huang T H, Yang Q, Harada M, Uberai J, Radford J, Li G Q, Yamahara J,
Roufogalis B D, Li Y. Salacia oblonga root improves cardiac lipid metabolism
in zucker diabetic fatty rats: modulation of cardia PPAR-alpha-mediated
transcription of fatty acid metabolic genes. Toxicol Appl Pharmacol.
2006;210(1-2):78-85.
91. Huang TH, Peng G, Li G Q, Yamahara J, Roufogalis BD, Li Y. Salacia
oblonga root improves postprandial hyperlipidemia and hepatic steatosis in
Zucker diabetic fatty rats: Activation of PPAR-alpha. Toxicol Appl
Pharmacol. 2006;210(3):225-235.
92. Flammang AM, Erexson GL, Mecchi MS, Murli H. Genotoxicity testing of a
Salacia oblonga extract. Food Chem Toxicol. 2006;44(11):1868-1874.
93. Williams JA, Choe YS, Noss MJ, Baumgartner CJ, Mustad VA. Extract of
Salacia oblonga lowers acute glycemia in patients with type 2 diabetes. Am J
Clin Nutr.2007;86:124-130.
94. Hertzler S, Washam M,Williams J. Salacia oblonga extract reduces
postprandial glycemia following a solid, high-starch meal. The FASEB
Journal. 2007;21:832-839.
95. Huang TH, He L, Qin Q, Yang Q, Peng G, Harada M, Qi Y, Yamahara
J, Roufogalis B D, Li Y.Salacia oblonga root decreases cardiac hypertrophy in
Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II
type 1 receptor. Diabetes, Obesity and Metabolism.2008;10(7):574-585.
203
96. Rong X, Kim M S, Su N, Wen S, Matsuo Y, Yamahara J, Murray M, Li Y.
An aqueous extract of Salacia oblonga root, a herb-derived peroxisome
proliferator-activated receptor-alpha activator, by oral gavage over 28 days
induces gender-dependent hepatic hypertrophy in rats. Food Chem
Toxicol.2008;46(6):2165-2172.
97. Li Y, Huang TH, Yamahara J. Salacia root, a unique Ayurvedic medicine,
meets multiple targets in diabetes and obesity. Life Sci. 2008;82(21-22):1045-
1049.
98. He L, Qi Y, Rong X, Jiang J, Yang Q, Yamahara J, Murray M, Li Y. The
ayurvedic medicine Salacia oblonga attenuates diabetic renal fibrosis in rats:
suppression of angiotensin II/AT1 signaling. Evid Based Complement
Alternat Med. 2011, Article ID 807451, 12 pages.
99. Singh NK, Biswas A, Rabbani SI, Devi K, Khanam S. Hydroalcoholic root
bark extract of Salacia oblonga prevented mitomycin-C induced sperm
abnormality in wistar rats. Phcog Mag;2009;5(19):254-259.
100. Giron MD, Sevillano N, Salto R, Haidour A, Manzano M, Jimenez ML, Rueda
R, López-Pedrosa JM. Salacia oblonga extract increases glucose transporter 4-
mediated glucose uptake in L6 rat myotubes: role of mangiferin. Clinical
Nutrition 2009;28(5):565-574.
101. Donga JJ, Surani VS, Sailor GU, Chauhan SP, Seth AK. A Systematic
Review on Natural Medicine Used For Therapy of Diabetes Mellitus of Some
Indian Medicinal Plants. Pharma Science Monitor. An International Journal of
Pharmaceutical Sciences. 2011;2(1):36- 72.
102. Sahayam C S, Dubey GP, Rajamanickaam GV, Brindha P. Comparative study
of anti diabetic potential of Salacia species in Hippocrateaceae family. Journal
of Pharmacy Research. 2011;4(4):1113-1114. Available online through:
www.jpronline.info
103. Nakata K, Taniguchi Y, Yoshioka N, Yoshida A, Inagawa H, Nakamoto T,
Yoshimura H, Miyake S, Kohchi C, Kuroki M, Soma G I. A mixture of
Salacia oblonga extract and IP-PA1 reduces fasting plasma glucose (FPG) and
low-density lipoprotein (LDL) cholesterol levels. Nutrition Research and
Practice (Nutr Res Pract) 2011;5(5):435-442.
204
104. Kim M S, Huang T H W, Li G Q, Li Y, Roufogalis B D. Natural medicinal
products in diabetes research- Salacia oblon ga. Abstracts from the Third
International Congress on Complementary Medicine Research 2008. Abstract
No: 153. S-44.
105. Williams J A. A Novel Approach for Lowering Postprandial Glycemia.
www.AbbottNutritionHealthInstitute.org
106. Claus CR. Drugs producing diabetes through damage of the insulin
secreting cells. In : Pharmacological reviews. Williams and Wilkins
Company. 1970;22:508-517.
107. Srinivasan K., Ramarao P. Animal models in type 2 diabetes research: An
overview. Indian J Med Res. 2007;125:451-472.
108. Wei M, Ong L, Smith MT, Ross FB, Schmid K, Hoey AJ, Burstow
D, Brown L.The streptozotocin-diabetic rat as a model of the chronic
complications of human diabetes. Heart Lung Circ.2003;12:44-50.
109. Weinberg ME, Bacchetti P, Rushakoff RJ. Frequently Repeated Glucose
Measurements Overestimate the Incidence of Inpatient Hypoglycemia and
Severe Hyperglycemia. J Diabetes Sci Technol 2010;4(3):577-582
110. Certificate of analysis. Product Name: Gymnema sylvestre extract. Batch
No:GS/08001. Quality control department, Natural Remedies Private
Limited, 5B, Veerasandra Indl.Area, Hosur Road, Bangalore-560100.
111. Certificate of analysis. Product Name: Salacia oblonga extract. Batch
No:GS/08001. Quality control department, Natural Remedies Private
Limited, 5B, Veerasandra Indl.Area, Hosur Road, Bangalore-560100.
112. Deshpande SS, Shah GB, Parmar NS. Antiulcer activity of Tephrosia
purpurea in rats. Indian Journal of Pharmacology. 2003;35:168-172.
113. Bidhe R M, Ghosh S. Acute and Subchronic (28-Day) Oral Toxicity Study
in Rats Fed with Novel Surfactants. AAPS PharmSci 2004;6 (2) Article 14
(http://www.aapspharmsci.org).
114. Selvan VT, Manikandan L, Kumar GPS, Suresh R, Kakoti BB, Gomathi P,
Kumar DA, Saha P, Gupta M, Mazumder UK. Antidiabetic and Antioxidant
Effect of Methanol Extract of Artanema sesamoides in Streptatozocin-
Induced Diabetic Rats. International Journal of Applied Research in Natural
Products. 2008;1(1):25-33.
205
115. Rathi SS, Grover JK, Vikrant V, Biswas NR. Prevention of experimental
diabetic cataract by Indian Ayurvedic plant extracts. Phytother Res.
2002;16(8):774-777.
116. Suryanarayana P, Saraswat M, Petrash JM, Reddy GB. Emblica officinalis
and its enriched tannoids delay streptozotocin induced diabetic cataract in
rats. Molecular Vision 2007; 13:1291-7 Available at:
http://www.molvis.org/molvis/v13/a141/
117. Makino H, Tanaka I, Mukoyama M, Sugawara A, Mori K, Muro S,
Suganami T, Yahata K, Ishibashi R, Ohuchida S, Maruyama T, Narumiya S,
Nakao K. Prevention of Diabetic Nephropathy in Rats by Prostaglandin E
Receptor EP1-Selective Antagonist. J Am Soc Nephrol 2002; 13:1757–
1765.
118. Roche Diagnostics GmbH. D-68298 Mannheim, Germany. www.accu-
chek.com
119. Karl J. Development of Standardisation of a New Immunoturbidimetric
HbA1c Assay. Klin Lab 1993;39:991-996.
120. LINCO Research, 6 Research Park, Dr.St.Charles, Missouri 63304 USA.
121. Siedel J. AACC Meeting Abstract 34. Clin Chem 1993;39:1127.
122. Tietz NW. Clinical Guide to Laboratory Tests, 3rd ed. Philadelphia, Pa: WB
Saunders Company, 1995:130-131.
123. Sugiuchi H, Uji Y, Okabe H, Irie T. Direct Measurement of High-Density
Lipoprotein Cholesterol in Serum with Polyethylene Glycol-Modified
Enzymes and Sulfated -Cyclodextrin. Clin Chem 1995; 41 : 717-723.
124. Matsuzaki Y, Kawaguchi E, Morita Y. Evaluation of Two Kinds of
Reagents for Direct Determination of HDL-Cholesterol. J Anal Bio-Sc
1996;19:419-427.
125. Talke H, Schubert GE. Enzymatische Harnstoffbestimmung im Blut und
Serum im optischen Test nach Warburg. Klin Wschr 1965;43:174-175.
126. Foster-Swanson A, Swartzentruber M, Roberts P. Reference Interval Studies
of the Rate-Blanked Creatinine/Jaffe’ Method on BM/Hitachi Systems in Six
U.S. Laboratories. Clin Chem 1994; Abstact No. 361.
206
127. Bergmeyer HU, Horder M, Rej R. Approved recommendation (1985) on
IFCC methods for the measurement of catalytic concentration of enzymes.
Part 2. IFCC Method for aspartate aminotransferase. J Clin Chem Clin
Biochem 1986;24:497-508.
128. Bergmeyer HU, Horder M, Rej R. Approved recommendation (1985) on
IFCC methods for the measurement of catalytic concentration of enzymes.
Part 3. IFCC Method for alanine aminotransferase. J Clin Chem Clin
Biochem 1986;24:481-489.
129. Tietz NW, Rinker AD, Shaw LM. IFCC Methods for the Measurement of
Catalytic Concentration of Enzymes. Part 5. IFCC Method for Alkaline
Phosphatase. J. Clin. Chem. Clin. Biochem. 1983;21:731-748.
130. Klauke R, Schmidt E, Lorentz K. Recommendations for carrying out
standard ECCLS procedures (1988) for the catalytic concentrations of
creatine kinase, aspartate aminotransferase, alanine aminotransferase and γ-
glutamyltransferase at 37˚C. Eur J Clin Chem Clin Biochem 1993;31:907-
909.
131. Multi center study of Tina-quant Albumin in urine and β- N-acetyl-
glucosaminidase (β –NAG) in urine. Workshop Munich, November 29-30,
1990. Wien Klin Wschr.1991; 103, supplement189:1-64.
132. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement
with Folin Phenol Reagent. J Biol Chem 1951;193:265-275.
133. Tietz NW: Methods of determination of ascorbic acid. In : Text book of
clinical biochemistry. Nw Tietz, Ed, WB Saunders Company, Philedelphia
London, Toronto. 1986:960-962.
134. Butler. Estimation of Glutathione content of RBC and whole blood. J. Lab.
And Clin Med.1963;61:882.
135. Stocks J., Dormandy TL. The autooxidation of human red cell lipids. Br. J.
Haematol. 1971; 20:95-111.
136. Levine RL, Garland D, Oliver CN, Amiei A, Climent I, Lenz AG.
Determination of carbonyl content in oxidatively modified proteins. Meth.
Enzymol. 1990; 86:464-478.
137. Ellman GL. Measurement of protein thiols in plasma. Arch Biochem
Biophy. 1959 ; 82 : 70.
207
138. Lo S, Russell J C, Taylor A W. Determination of glycogen in small tissue
samples. J Appl Physiol. 1970;28(2):234-236.
139. Culling CFA. Handbook of Histopathological and Histochemical
Techniques (1974). Butterworth, London.
140. Sigma –Aldrich Corporation. 3050 Spruce St., St. Louis, Missouri 63103.
United States.
141. Ueda E, yoshikawa Y, Sakurai H, Kojima Y, Kajiwara N M. In Vitro
Alpha-glucosidase Inhibitory Effect of Zn(II) Complex with 6-Methyl- 2-
picolinmethylamide. Chem. Pharm. Bull.2005;53(4):451—452 .
142. Agappe Diagnostics Ltd. ‘Agappe Hills’, Dist Ernakulam, Kerala- 683562.
India.
143. Dagher Z, Park Y S, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M.
Studies of Rat and Human Retinas Predict a Role for the Polyol Pathway in
Human Diabetic Retinopathy. Diabetes. 2004; 53:2404–2411.
144. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M. A role for the
polyol pathway in the early neuroretinal apoptosis and glial changes induced
by diabetes in the rat. Diabetes 2003;52(2):506 –511.
145. Obrosova IG, Minchenko AG, Vasupuram R, White L, Abatan OI,
Kumagai AK, Frank RN, Stevens MJ. Aldose reductase inhibitor fidarestat
prevents retinal oxidative stress and vascular endothelial growth factor
overexpression in streptozotocin-diabetic rats. Diabetes 2003;52(3):864–
871.
146. Obrosova IG, Pacher P, Szabo C, Zsengeller Z, Hirooka H, Stevens MJ,
Yorek M A. Aldose reductase inhibition counteracts oxidative-nitrosative
stress and poly(ADP-ribose) polymerase activation in tissue sites for
diabetes complications. Diabetes 2005;54:234 –242.
147. Sun W, Oates P J, Coutcher J B, Gerhardinger C, Lorenzi M. A Selective
Aldose Reductase Inhibitor of a New Structural Class Prevents or Reverses
Early Retinal Abnormalities in Experimental Diabetic Retinopathy. Diabetes
2006;55(10):2757–2762.
148. Srivastava S K, Ramana KV, Bhatnagar A. Role of Aldose Reductase and
Oxidative Damage in Diabetes and the Consequent Potential for Therapeutic
Options. Endocrine Reviews 2005;26(3):380–392.
208
149. Falcão M, Falcão-Reis F, Rocha-Sousa A. Diabetic Retinopathy:
Understanding Pathologic Angiogenesis and Exploring its Treatment
Options. The Open Circulation and Vascular Journal 2010;3:30-42.
150. Ciulla T A, Amador A G, Zinman B. Diabetic Retinopathy and Diabetic
Macular Edema. Pathophysiology, screening, and novel therapies. Diabetes
Care. 2003;26:2653–2664.
151. Kennedy A, Frank RN, Varma SD. Aldose reductase activity in retinal and
cerebral microvessels and cultured vascular cells. Invest Opthalmol &
Visual Sci 1983;24(9):1250–1258.
152. Yabe-NishimuraC. Aldose Reductase in Glucose Toxicity: A Potential
Target for the Prevention of Diabetic Complications. Invest Opthalmol &
Visual Sci 1998;50:21-33.
153. Mansou M A. Aldose Reductase in the Retina. Current Enzyme Inhibition.
2007;3(1):49-60.
154. Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH.
Prevention of retinal vessel changes associated with diabetic retinopathy in
galactose-fed dogs by aldose reductase inhibitors. Arch
Ophthalmol. 1990;108(9):1301-1309.
155. Robison WG Jr, Nagata M, Laver N, Hohman TC, Kinoshita JH. Diabetic
like retinopathy in rats prevented with an aldose reductase inhibitor. Invest
Opthalmol & Visual Sci 1989;30(11):2285–2292.
156. Chakrabarti S, Sima A A. Effect of aldose reductase inhibition and insulin
treatment on retinal capillary basement membrane thickening in BB rats.
Diabetes 1989; 38(9):1181–1186. abstract
157. Suryanarayana P, Anilkumar P, Saraswat M, Petrash J M, Reddy G B.
Inhibition aldose reductase by tannoid principles of Emblica officinalis:
Implications for the prevention of sugar cataract. Molecular
Vision.2004;10:148-54. Available online at:
<http://www.molvis.org/molvis/v10/a20>
158. Afkhami-Ardekani M, Shojaoddiny-Ardekani A. Effect of vitamin C on
blood glucose, serum lipids & serum insulin in type 2 diabetes patients.
Indian J Med Res 2007;126:471-474.
159. Maritin AC, Sanders RA, Watkins JBIII. Diabetes, oxidative stress and anti
oxidants. J Biochem Molecular Toxicology. 2003;17(1):24-38.
209
160. Fagerberg SE. Diabetic neuropathy: a clinical and histologic study on the
significance of vascular affections. Acta Med Scand 1959;164:1–80.
161. Colciago A, Negri-Cesi P, Celotti F. Pathogenesis of diabetic neuropathy -
do hyperglycemia and aldose reductase inhibitors affect neuroactive steroid
formation in the rat sciatic nerves? Exp Clin Endocrinol Diabetes
2002;110:22-26.
162. Greene DA, Lattimer SA, Sima AA. Sorbitol, phosphoinositides, and
sodium-potassium-ATPase in the pathogenesis of diabetic complications. N
Engl J Med 1987;316:599–606.
163. Nishimura C, Lou MF, Kinoshita JH. Depletion of myo-inositol and amino
acids in galactosemic neuropathy. J Neurochem 1987;49(1):290–295.
164. Chakrabarti S, Sima A A, Nakajima T, Yagihashi S, Greene D A. Aldose
reductase in the BB rat: isolation, immunological identification and
localization in the retina and peripheral nerve. Diabetologia 1987;30:244–
251.
165. Chakraborty U, Das H. Antidiabetic and Anti oxidant activities of
Cinnamomum tamala leaf extract in STZ-treated diabetic rats. Global J
Biotechnology and Biochemistry. 2010;5(1):12-18.
166. Shigeki E, Yoshihito O, Aysegül G, Ceyda Sibel E, Maskut CK., Toru O.
Inhibitory Effect of Traditional Turkish Folk Medicines on Aldose
Reductase (AR) and Hematological Activity, and on AR Inhibitory Activity
of Quercetin-3-O-methyl Ether Isolated from Cistus laurifolius L. Biol.
Pharm. Bull. 2004;27(7):1140—1143.
167. Hussain H E M A. Reversal of diabetic retinopathy in streptozotocin induced
diabetic rats using traditional Indian antidiabetic plant, Azadirachta indica
(L.). Ind J Clin Biochem 2002;17(2):115-123.
168. Anderson RS, Trune DR, Shearer TR. Histologic Changes in Selenite
Cortical Cataract. Investigative Ophthalmology & Visual Science
1988;29(9):1418-1427.
169. Sandberg HO , Closs O. The alpha and gamma crystalline content in
aqueous humor of eyes with clear lenses and with cataracts. Exp Eye Res
1979;28:601-610.
210
170. Linklater HA, Dzialoszynski T, McLeod HL, Sanford SE, Trevithick JR.
Modelling cortical cataractogenesis: VII. Effects of butylated
hydroxytoluene (BHT) in reducing protein leakage from lenses in diabetic
rats. Exp Eye Res 1986;43(3):305-314.
171. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 2000;
49(2 Suppl 1):27-29.
172. Lapolla A, Traldi P, Fedel D. Importance of measuring products of non-
enzymatic glycation of proteins. Clinical Biochemistry.2005;38(2):103–115.
173. Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early
glycation products: a mechanism for accelerated atherogenesis in diabetes.
Biochem Biophys Res Commun 1990; 173:932-938.
174. McLennan SV, Heffernan S, Wright L, Rae C, Fisher E, Yue DK, Turtle JR.
Changes in hepatic glutathione metabolism in diabetes. Diabetes 1991;
40(3):344-348.
175. Strain J J. Disturbances of micronutrient and antioxidant status in diabetes.
Proc Nutr Soc 1991; 50(3):591-604.
176. Baynes J W. Role of oxidative stress in development of complications in
diabetes. Diabetes 1991; 40:405-412.
177. Alderson NL, Chachich ME, Frizzell K, Canning P, Metz TO, Januszewski
A S, Youssef O, Stitt A, Baynes J, Thorpe S. Effect of antioxidants and
ACE inhibition on chemical modification of proteins and progression of
nephropathy in the streptozotocin diabetic rat. Diabetologia 2004;47:1385–
1395.
178. Tiwari A K, Rao J M. Diabetes mellitus and multiple therapeutic
approaches of phytochemicals: Present status and future prospects.
CURRENT SCIENCE. 2002; 83(1):30-38.
179. Packer L, Rfsen P, Tritschler HJ, King GL, Azzi A, 2000. Antioxidants in
Diabetes Management. Marcel Dekker, New York, pp. 1–338.
180. Polidori MC, Mecocci P, Stahl W, Parente B, Cecchetti R, Cherubini A,
Cao P, Sies H, Senin U. Plasma levels of lipophilic antioxidants in very old
patients with Type 2 diabetes Diab. Metab. Res. Rev. 2000;16(1):15–19.
181. Price K D, Price C S C, Reynolds R D. Hyperglycemia-induced ascorbic
acid deficiency promotes endothelial dysfunction and the development of
atherosclerosis. Atherosclerosis 2001;158(1): 1–12.
211
182. Valabhji J, Mc Coll AJ, Richmond W, Schachter M, Rubens MB, Elkeles
RS. Total Antioxidant Status and Coronary Artery Calcification in Type 1
Diabetes. Diabetes Care 2001;24(9):1608–1613.
183. Atanasiu RL, Stea D, Mateescu MA, Vergely C, Dalloz F, Briot F, Maupoil
V, Nadeau R, Rochette L. Direct evidence of ceruloplasmin antioxidant
properties. Mol Cell Biochem 1998; 189(1-2): 127–135.
184. Chatterjee IB, Nandi A. Ascorbic acid scavenges of oxyradicals. Indian J
Biochem Biophys 1991; 28: 233–236.
185. Infers H, Sies H. The protection by ascorbate and glutathione against
microsomal lipid peroxidation is dependent on vitamin E. Eur J Biochem
1988:74: 353–357.
186. Irshad M, Chaudhuri PS. Oxidant – antioxidant system; role and significance
in human body. Indian J Exp Biol 2002; 40(11): 1233–1239.
187. Sies H. Glutathione and its role in cellular functions. Free Radical Biology
and Medicine.1999;27(9–10) :916–921.
188. Madhu CG, Ojha S, Bansal DD. Antioxidant status of streptozotocin diabetic
rats. Indian J Exp Biol 1996;34(3): 264–266. abstract
189. Dewanjee S, Maiti A, Sahu R, Dua T K, Mandal V. Effective Control of
Type 2 Diabetes through Antioxidant Defense by Edible Fruits of Diospyros
peregrine. Evidence-Based Complementary and Alternative Medicine.
2011; Article ID 675397: 1- 7.
190. Awanti S M, Baruah P S, Prakash M. Serum and urine protein thiols in Type
2 diabetes mellitus patients. Indian J Physiol Pharmacol 2009; 53(2): 185-
188.
191. Yin P, Zhao S, Chen S, Liu J, Shi L, Wang X, Liu Y, Ma C. Hypoglycemic
and Hypolipidemic Effects of Polyphenols from Burs of Castanea
mollissima Blume. Molecules 2011;16: 9764-9774. Available at:
doi:10.3390/molecules16119764.
192. Shirwaikar A, Rajendran K, Kumar C D. Oral Antidiabetic Activity of
Annona squamosa Leaf Alcohol Extract in NIDDM Rats. Pharm boil. 2004;
42: 30-35.
193. Barreiro E, Gea J, Falco M D, Kriazhev L, James S, Hussain S N A. Protein
carbonyl formation in the diaphragm. Am J Respir Cell Mol Biol 2005;
32(1): 9-17.
212
194. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein
carbonyl groups as biomarkers of oxidative stress. Clinica Chimica Acta
2003;329(1-2):23–38.
195. Zhang XF, Tan BKH. Antihyperglycemic and antioxidant properties of
Andrographis paniculata in normal and diabetic rats. Clin Exp Pharmacol
Physiol 2000;27:358-363.
196. Soon YY, Tan BKH. Evaluation of the Hypoglycemic and Anti- Oxidant
Activities of Morinda officinalis in Streptozotocin-induced Diabetic Rats.
Singapore Med J 2002; 43(2): 077-085.
197. Sathishsekar D, Subramanian S. Antioxidant properties of Momordica
Charantia (bitter gourd) seeds on Streptozotocin induced diabetic rats. Asia
Pac J Clin Nutr 2005;14:153-158.
198. Sabu MC, Kuttan R. Antidiabetic activity of Aegle marmelos and its
relationship with its antioxidant properties. Indian J Physiol Pharmacol
2004; 48(1): 81-88.
199. Raghavan B, Krishnakumari S. Effect of Terminalia arjuna stem bark on
antioxidant status in liver and kidney of alloxan diabetic rats. J Physiol
Pharmacol 2006; 50(2): 133-142.
200. Shibata S, Natori Y, NishiharaT, Tomisaka K, Matsumoto K, Sansawa H,
Nguyen V C. Antioxidant and anti cataract effects of Chlorella on rats with
STZ-induced diabetes. J Nutr Sci Vitaminol 2003;49:334-9.
201. Kasi R, Balasubramanian R, Sorimuthu S. Protective Effect of Eugenia
jambolana Seed Kernel on Tissue Antioxidants in Streptozotocin-Induced
Diabetic Rats. Biol. Pharm. Bull.2004;27:1212—1217.
202. Sarkar R, Hazra B, Biswas S, Mandai N. Evaluation of the in vitro
antioxidant and iron chelating activity of Gymnema sylvestre.
Pharmacologyonline 2009;3: 851-865.
203. Rachh PR, Patel SR, Hirpara HV, Rupareliya MT, Rachh MR, Bhargava AS,
Patel NM, Modi DC. In vitro evaluation of antioxidant activity of Gymnema
sylvestre R. Br. leaf extract. Rom. J. Biol. – Plant Biol.2009;54(2):141–148.
204. Fazal H, Ahmad N, Khan M A. Physico-chemical, phytochemical evaluation
and dpph-scavenging antioxidant potential in medicinal plants used for
herbal formulation in Pakistan . Pak. J. Bot. 2011; 43:63-67.
213
205. Zargar AH, Wandroo F A, Wadhwa MB, Laway BA, Masoodi SR, Shah
NA. Serum Lipid Profile in Non-insulin-dependent Diabetes Mellitus
Associated with Obesity Int. J. Diab. Dev. Countries 1995;15:9-13.
206. Miller CJ, Dunn EV, Hashim IB. Glycemic index of 3 varieties of dates.
Saudi Med. J. 2002;23(5):536-538.
207. Pari L, Latha M. Effect of Cassia Auriculata Flowers on Blood Sugar
Levels, Serum and Tissue Lipids in Streptozotocin Diabetic Rats. Singapore
Med J. 2002;43(12): 617-621.
208. Andallu B, Vinaykumar AV, Varadacharyulu NCh. Lipid abnormalities in
streptozotocin diabetes: Amelioration by Morus indica L. cv Suguna leaves.
Int J Diab Dev Ctries 2009; 29: 123-128.
209. Al-Jamal A, Alqadi T. Effects of Rosemary (Rosmarinus officinalis) on
Lipid Profile of Diabetic Rats. Jordan Journal of Biological
Sciences.2011;4(4):199–204.
210. Chait A, Brunzell JD, LeRoith D, Taylor SI, Olefsk JM. Diabetes, lipids, and
atherosclerosis. In: (Eds.), Diabetes Mellitus. Lippincott-Raven Publishers,
Philadelphia.1996 pp. 467–469.
211. Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetiere P, Thibult
N Warnet JM, Claude JR, Rosselin GE.Hypertriglyceridaemia as a risk
factor of coronary heart disease mortality in subjects with impaired glucose
tolerance or diabetes. Diabetologia 1989;32,300–304.
212. Tanwy WHE, Hassanin LA. Hypoglycemic and hypolipidemic effects of
alcoholic extract of Tribulus alatus in streptozotocin –induced diabetic rats:
A comparative study with T.terrestris (Caltrop). Ind J Expt Biol
2007;45:785-790.
213. Pushparaj P, Tan CH, Tan BKH. Effects of Aerrhoa bilimbi leaf extract on
blood glucose and lipids in streptozotocin-diabetic rats. Journal of
Ethnopharmacology 2000; 72: 69–76.
214. Luo Q, Cai Y, Yan J, Sun M, Corke H. Hypoglycemic and hypolipidemic
effects and antioxidant activity of fruit extracts from Lycium barbarum. Life
Sciences 2004; 76: 137–149.
215. Vasudevan DM, Sreekumari S. Textbook of Biochemistry For Medical
Students (4th Ed). New Delhi, JAYPEE Brothers Medical Publishers (P) Ltd.
2005.
214
216. Sharma A, Mathur R, Shukla S. Hepatoprotective action of a proprietary
herbal preparation against carbon tetrachloride intoxication. Indian Drugs
1995;32:120-124.
217. Eder EE, Atangwho IJ, Akpanabiatu MI, Eder TE, Uboh FE, David-Oku E.
Effect of Gongronema latifolium leaf extract on some liver enzymes and
protein levels in diabetic and non diabetic rats. J Pharm Biomed Sci
2011;1:104-107.
218. Ilango K, Chitra V. Hepatoprotective and Antioxidant Activities of Fruit
pulp of Limonia acidissima Linn. International Journal of Health Research
2009; 2(4): 61-367. Available at http://www.ijhr.org
219. Mohamed Saleem TS, Christina AJM, Chidambaranathan N, Ravi V,
Gauthaman K. Hepatoprotective activity of Annona squamosa Linn. on
experimental animal model International Journal of Applied Research in
Natural Products 2008; 1(3): 1-7. Available online http://www.healthy-
synergies.com
220. Neuschwander-Tetri BA, Caldwell S H. Nonalcoholic steatohepatitis.
Summary of AASLD single topic conference. Hepatology 2003;37(5):1202-
1219.
221. Haris E H. Elevated liver function tests in type 2 diabetes. Clinical Diabetes
2005; 23(3):115-119.
222. Guven A, Yavuz O, Cam M, Ercan F, Bukan N, Comunoglu C, Gokce F.
Effects of melatonin on streptozotocin-induced diabetic liver injury in rats.
Acta histochemica 2006;108:85-93.
223. Saeed M K, Deng Y, Dai R. Attenuation of Biochemical Parameters in
Streptozotocin-induced Diabetic Rats by Oral Administration of Extracts
and Fractions of Cephalotaxus sinensis. J. Clin. Biochem. Nutr.
2008;42(1):21–28.
224. Nuhu AA, Aliyu R. Effects of Cassia occidentalis aqueous leaf extract on
biochemical markers of tissue damage in rats. Tropical Journal of
Pharmaceutical Research 2008;7: 1137-1142.
225. Ogbonnia S, Adekunle A A, Bosa M K, Enwuru V N. Evaluation of acute
and subacute toxicity of Alstonia congensis Engler (Apocynaceae) bark and
Xylopia aethiopica (Dunal) A. Rich (Annonaceae) fruits mixtures used in the
treatment of diabetes. African Journal of Biotechnology. 2008;7:701-705.
215
226. Udayakumar R Kasthurirengan S, Mariashibu T S, Rajesh M, Anbazhagan V
R Kim, S C, Ganapathi A, Choi C W. Hypoglycemic and hypolipidemic
effects of Withania somnifara root and leaf extracts on alloxan-induced
diabetic rats. Int J Mol Sci 2009;10:2367-2382. Available online at:
www.mdpi.com/journal/ijms
227. Jung C H, Zhou S, Ding G X, Kim J H, Hong M H, Shin Y C, Kim G J, Ko
S G. Antihyperglycemic activity of herb extracts on streptozotocin induced
diabetic rats. Biosci Biotechnol Biochem 2006; 70: 60238- 1-4.
228. Srividya A R, Varma S K, Dhanapal S P, Vadivelan R, Vijayan P.Invitro
and invivo evaluation of hepatoprotective activity of Gymnema sylvestre. Int
J Pharmaceutical Sci and Nanotechnology 2010; 2(4): 768-773.
229. Gray CH, Howorth PJN. Clinical chemical pathology. Edward Arnold
Publishers, 1980; 80-99.
230. Pimple BP, Kadam PV, Bafna NS, Patil MJ. Protective effect of Tamarindus
indica Linn. against paracetamol-induced hepatotoxicity in rats. Ind J
Pharmaceutical Sciences 2007;69:827-831.
231. Iweala E E J, Oludare F D. Hypoglycemic effect, biochemical and
histological changes of Spondias mombin Linn. and Parinari polyandra
Benth. seeds ethanolic extracts in alloxan-induced diabetic rats. J Pharmac
Toxicol 2011; 6(2):101-112.
232. Sambo N, Garba SH, Timothy H. Effect of the aqueous extract of Psidium
guajava on erythromycin-induced liver damage in rats. Niger J Physiol
Sci. 2009;24(2):171-6.
233. Singh N, Gupta M. Regeneration of β-cells in islets of langerhans of
pancreas of alloxan diabetic rats by acetone extract of Momordica charantia
(Linn.) (bitter gourd) fruits. Indian J Experimental Biology. 2007;45:1055-
1062
234. Nayak S B, Marshall J R, Isitor G, Adogwa A. Hypoglycemic and
Hepatoprotective Activity of Fermented Fruit Juice of Morinda citrifolia
(Noni) in Diabetic Rats Evidence-Based Complementary and Alternative
Medicine. 2011; Article ID 875293: 5 pages. Available at:
doi:10.1155/2011/875293.
216
235. Sunil C, Latha PG, Suja SR, Shine VJ, Shyamal S, Anuja GI, Sini S,
Rajasekharan S, Agastian P, Ignacimuthu S, Kalichelvan V. Effect of
Ethanolic Extract of Pisonia alba Span.Leaves on Blood Glucose levels and
Histological Changes in Tissues of Alloxan-Induced Diabetic rats.
International Journal of Applied Research in Natural Products. 2009;2(2):4-
11.
236. Jothivel N, Ponnusamy S P, Appachi M, Singaravel S, Rasilingam D,
Deivasigamani K, Thangavel S. Anti-diabetic activity of methanol leaf
extract of Costus pictus D.Don in alloxan-induced diabetic rats. J of Health
Science.2007;53(6):655-663.
237. Zal F, Vasei M, Rasti M, Vessal M. Hepatotoxicity associated with
hypoglycemic effects of Teucrium polium in diabetic rats. Arch Irn Med
200;4(4):188-192.
238. Arun K, Balasubramanian U. Comparative study on Hepatoprotective
activity of Aegle marmelos and Eclipta alba against alcohol induced in
albino rats. International Journal of Environmental Sciences.2011;2:389-
402.
239. Khalil EAM. Biochemical and histopathological studies on the influence of
aqueous extract of fenugreek seed (Trigonella foenum graecum) on alloxan
diabetic male rats. The Egyptian Journal of Hospital Medicine 2004;15 :83 –
94.
240. Jayanthi M, Sowbala N, Rajalakshmi G, Kanagavalli U, Sivakumar V. Study
of anti hyperglycemic effect of Catharanthus roseus in alloxan induced
diabetic rats. Int J Pharm Sci 2010;2(4):114-116.
241. Lloberas N, Cruzado JM, Franquesa M, Herrero-Fresneda I, Torras J,
Alperovich G, Rama I, Vidal A, Grinyo JM. Mammalian Target of
Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney
Disease in Rats. J Am Soc Nephrol 17: 1395–1404, 2006. doi:
10.1681/ASN.2005050549
242. Remuzzi G, Benigni A, Remuzzi A. Mechanism of progression and
regression of renal lesions of chronic nephropathies and diabetes. J Clin
Invest. 2006;116(2):288–296. Available at: doi: 10.1172/JCI27699
217
243. Remuzzi A, Gagliardini E, Donadoni C, Fassi A, Sangalli F, Lepre MS,
Remuzzi G, Benigni A. Effects of angiotensin II antagonism on the
regression of kidney disease in the rat. Kidney Int. 2002;62(3):885-894.
244. Adamczak M, Gross ML, Krtil J, Koch A, Tyralla K, Amann K, Ritz E.
Reversal of glomerulosclerosis after high-dose enalapril treatment in
subtotally nephrectomised rats. J Am Soc Nephrol. 2003;14:2833-2842.
245. Mauer S M, Steffes M W, Ellis E N, Sutherland D E, Brown D M, Goetz
F C. Structural-Functional Relationships in Diabetic Nephropathy. J. Clin.
Invest. 1984;74(4):1143-1155.
246. Upadhya S, Shanbhag KK, Suneetha G, Balachandra Naidu M, Upadhya S.
A study of hypoglycemic and antioxidant activity of Aegle marmelos in
alloxan induced diabetic rats. Indian J Physiol Pharmacol 2004; 48(4):476-
480.
247. Mittal M, Juyal V, Singh A. Phytochemical, Antidiabetic, and
Cytoprotective Properties of Berberis aristata DC. Root Extracts.
Pharmaceutical Crops 2012; 3: 64-68.
248. Hussain H E M A. Hypoglycemic, hypolipidemic and antioxidant properties
of combination of curcumin from Curcuma longa, linn, and partially purified
product from Abroma augusta, linn. In streptozotocin induced diabetes
.Indian Journal of Clinical Biochemistry 2002; 17:33-43.
249. Shanmugam KR, Ramakrishna CH, Mallikarjuna K, Reddy K S. Protective
effect of ginger against alcohol- induced renal damage and anti oxidant
enzymes in male albino rats. Indian Journal of Experimental Biology
2010;48:143-149.
250. Marouane W, Soussi A, Murat JC, Bezzine S, Feki AEI. The protective
effect of Malva sylvestris on rat kidney damaged by vanadium. Lipids in
Health and Disease 2011, 10:65.
http://www.lipidworld.com/content/10/1/65.
251. Rosalina Tan RT, Mohamed S, Samaneh G F, Noordin MM, Goh YM,
Manap MYA. Polyphenol rich oil palm leaves extract reduce
hyperglycaemia and lipid oxidation in STZ-rats. International Food Research
Journal 2011;18: 179-188.
218
252. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML,
Zelmanovitz T. Diabetic Nephropathy: Diagnosis, Prevention, and
Treatment. Diabetes Care. 2005;28(1):164-176.
253. Anjaneyulu M, Chopra K. Quercetin an antioxidant bioflavanoid, attenuates
diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 2004;31: 244-248.
254. Berg TJ, Bangstad HJ, Torjesen PA, Osterby R, Bucala R, Hanseen KC.
Advanced glycation end products in serum predict changes in the kidney
morphology of patients with insulin-dependent diabetes mellitus.
Metabolism 1997; 46: 661-665.
255. Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic
nephropathy. Kidney International. 2000;77:S3-S12.
256. Sadiq S, Nagi AH, Shahzad M, Zia A. The reno-protective effect of aqueous
extract of Carum carvi (Black zeera) seeds in streptozotocin induced diabetic
nephropathy in rodents. Saudi J Kidney Dis Transplant .2010;21(6):1058-
1065.
257. Mauer SM, Lane P, Hattori M, Fioretto P, Steffes MW. Renal structure and
function in insulin-dependent diabetes mellitus and type-I
membranoproliferative glomerulonephritis in human. J Am Soc Nephrol
1992; 2: S181-S184.
258. Chang WP, Dimitriadis E, AllenT, Dunlop ME, Cooper ME, Larkins RG.
The effect of aldose reductase inhibitors on glomerular prostaglandin
production and urinary albumin excretion in experimental diabetes.
Diabetologia. 1991;34:225-231.
259. Rasch R, Mogensen CE. Urinary excretion of albumin and total protein in
normal and streptozotocin diabetic rats. Acta Endocrinol (Copenh). 1980;
95: 376–381.
260. Grover JK, Yadav SP, Vats V. Effect of feeding Murraya koeingii and
Brassica juncea diet on kidney functions and glucose levels in streptozotocin
diabetic mice. J Ethnopharmacol. 2003;85:1–5.
261. Yadav UCS, Moorthy K, Baquer NZ. Combined treatment of sodium
orthovanadate and Momordica charantia fruit extract prevents alterations in
lipid profile and lipogenic enzymes in alloxan diabetic rats. Mol Cell
Biochem. 2005;268:111–120.
219
262. Grover JK, Vats V, Rathi SS, Dawar R. Traditional Indian anti-diabetic
plants attenuate progression of renal damage in streptozotocin induced
diabetic mice. J Ethnopharmacol. 2001;76:233–238.
263. Sun L, Halaihel N, Zhang W, Rogers T, Levi M. Role of sterol regulatory
element-binding protein 1 in regulation of renal lipid metabolism and
glomerulosclerosis in diabetes mellitus. J Biol Chem. 2002;277:18919–
18927.
264. Meyer C, Stumvoll M, Nadkami V, Dostou J, Mitrakou A, Gerich J.
Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus.
J Clin Invest 1998;102:619–624.
265. Peterson DT, Greene WC, Reaven GM. Effect of experimental diabetes
mellitus on kidney ribosomal protein synthesis. Diabetes 1971; 20: 649–654.
266. Sunil C, Latha PG, Suja SR, Shine VJ, Shyamal S, Anuja GI et al. Effect of
Ethanolic Extract of Pisonia alba Span. Leaves on Blood Glucose levels and
Histological Changes in Tissues of Alloxan-Induced Diabetic rats.
International Journal of Applied Research in Natural Products. 2009;2:4-11.
267. Wang S, Lee S, Wang C, Lee C, Lee W, Lee H. Aqueous Extract from
Hibiscus sabdariffa Linnaeus Ameliorate Diabetic Nephropathy via
Regulating Oxidative Status and Akt/Bad/14-3-3γ in an Experimental
Animal Model. Evidence-Based Complementary and Alternative Medicine
2011; Article ID 938126: 9 pages.
268. El-Baky A E A, Amin H K. Effect of Citrullus colocynthis in ameliorate the
oxidative stress and nephropathy in diabetic experimental rats. International
Journal of Pharmaceutical Studies and Research.2011;2(2):1-10.
269. Baghian A, Lee KW. Role of activated macrophages in resistance to
systemic candidosis in beige mice.J med Vet Mycol . 1989;27: 51-55.
270. Raffel L, Pitsakis P, Levison SP, Levison ME. Experimental , and Candida
albicans, Staphylococcus aureus and Streptococcus faecalis pyelonephritis in
diabetic rats.Infect Immun 1981;34: 773-779.
271. Dangi KS, Mishra SN. Effect of Capparis aphylla stem extract treatment in
normal and streptozotocin induced diabetic rats infected with Candida
albicans. Asian J. Exp. Biol. Sci. 2011;2:102-107.
272. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells
of the rat pancreas. Physiological Research. 2001;50:536-546.
220
273. Bangar AV, Saralaya MG. Anti-hyperglycaemic activity of ethanol extract
and chloroform extract of Indigofera tinctoria leaves in streptozotocin
induced diabetic mice (Family- Papilionaceae). Research Journal of
Pharmaceutical, Biological and Chemical Sciences.2011;2(1):445-455.
274. Atangwho I J, Ebong P E, Egbung G E, Akpaso M I, Asuquo E E.
Histological Effect of Combined Extracts of Vernonia Amygdalina and
Azadirachta Indica on Normal and Diabetic Rats: the Pancreas and Liver.
Research Journal of Agriculture and Biological Sciences 2010;6(4):514-521.
275. Muthulingam M. Antidiabetic efficacy of leaf extracts of Asteracantha
longifolia (Linn.) Nees. on alloxan induced diabetics in male albino wistar
rats Int J Pharm Biomed Res 2010;1(2):28-34. Available online at:
www.pharmscidirect.com
276. Nagappa AN, Thakurdesai PA, Venkat Rao N, Jiwan Singh. Antidiabetic
activity of Terminalia catappa Linn fruits. J Ethnopharmacol 2003; 88: 45–
50.
277. Ahmed AB, Rao AS, Rao MV. In vitro callus and in vivo leaf extract
of Gymnema sylvestre stimulate β-cells regeneration and anti-diabetic
activity in Wistar rats. Phytomedicine 2010; 17(13):1033-1039.
278. Ahmed S M, Swamy BMV, Dhanapal P G R, Chandrashekara VM. Anti-
Diabetic Activity of Terminalia catappa Linn. Leaf Extracts in Alloxan-
Induced Diabetic Rats. Iranian J Pharmacology & Therapeutics 2005;4:36-
39.
279. Rajalakshmi M, Eliza J, Priya C E, Nirmala A, Daisy P. Anti-diabetic
properties of Tinospora cordifolia stem extracts on streptozotocin- induced
diabetic rats. African Journal of Pharmacy and Pharmacology. 2009;
3(5):171-180. Available online http://www.academicjournals.org/ajpp
280. Ahmed I, Adeghate E, Sharma AK, Pallot DJ, Singh J. Effects of
Momordica charantia fruit juice on islet morphology in the pancreas of the
streptozotocin-diabetic rat Diabetes Research and Clinical
Practice.1998;40:145-151.
281. Adeyemi DO, Komolafe OA, Adewole OS, Obuotor EM, Abiodun AA,
Adenowo TK. Histomorphological and morphometric studies of the
pancreatic islet cells of diabetic rats treated with extracts of Annona
muricata. Folia Morphol. 2010;69:92-100.
221
282. Prince PSM, Srinivasan M. Enicostemma littorale Blume aqueous extract
improves the antioxidant status in alloxan-induced diabetic rat tissues. Acta
Poloniae Pharmaceutica n Drug Research. 2005;62(5):363-367.
283. Adewole S O, Caxton-Martins E A. Morphological Changes and
Hypoglycemic Effects of Annona Muricata Linn. (Annonaceae) Leaf
Aqueous Extract on Pancreatic Β-Cells of Streptozotocin-Treated Diabetic
Rats. African Journal of Biomedical Research. 2006;9:173 – 187.
284. Montanya E, Nacher V, Biarnés M, Soler J. Linear Correlation Between β-
Cell Mass and Body Weight Throughout the Lifespan in Lewis Rats Role of
β-Cell Hyperplasia and Hypertrophy. Diabetes. 2000;49(8):1341–1346.
285. Kaurich T. Drug-induced acute pancreatitis. Proc (Bayl Univ Med Cent)
2008;21:77–81.
286. Bahnak B R, Gold A H. Effects of Alloxan Diabetes on the Turnover of Rat
Liver Glycogen Synthase, comparison with liver phosphorylase. The Journal
of Biological chemistry. 1982;257(15):8775-8780.
287. Clore JN, Post EP, Bailey DJ, Nestler JE, Blackard WG. Evidence for
increased liver glycogen in patients with noninsulin-dependent diabetes
mellitus after a 3 day fast. J of Clinical endocrinology and Metabolism.
1992;74:660-666.
288. Ferrannini E, Lanfranchi A, Rohner. Jeanrenaud F, Manfredini G, Vande
Werve G. Influence of long-term diabetes on liver glycogen metabolism in
the rat. Metabolism 1990; 39(10):1082-1088. Abstract
289. Gavin N, Levinthal, Anthony S Tavill. Liver disease and diabetes mellitus.
Clinical Diabetes 1999; 17:73.
http://journal.diabetes.org/clinicaldiabetes/v17n21999/Pg73.htm
290. Maiti R, Jana D, Das UK, Ghosh D. Antidiabetic effect of aqueous extract of
seed of Tamarindus indica in streptozotocin –induced diabetic rats. J
Ethnopharmacol. 2004;92(1):85-91.
291. Shirwaikar A, Rajendran K, Barik R. Effect of aqueous bark extract of
Garuga pinnata Robx. in streptozotocin induced type-II diabetes mellitus. J
Ethnopharmacol. 2006;107(2):285-290.
292. Ogihara M, Tokumitsu Y, Ui M. Metabolic alterations in normal and
streptozotocin-diabetic rats in vivo: influence of prolonged starvation. Jpn J
Pharmacol 1984;34:307–311.
222
293. Adeghate E. Effect of subcutaneous pancreatic tissue transplants on
streptozotocin-induced diabetes in rats. II. Endocrine and metabolic
functions. Tissue Cell. 1999;3:73–83.
294. Stalmans W, De Wulf H, Hers HG. The control of liver glycogen synthetase
phosphatase by phosphorylase. Eur J Biochem 1971;18:582–587.
295. Stalmans W, De Wulf H, Hue L, Hers HG. The sequential inactivation of
glycogen phosphorylase and activation of glycogen synthetase in liver after
the administration of glucose to mice and rats. Eur J Biochem 1974;41:127–
134.
296. Stalmans W, Laloux M, Hers HG. The interaction of liver phosphorylase a
with glucose and AMP. Eur J Biochem 1974;49:415–427.
297. Massillon D, Bollen M, De Wulf H, Overloop K, Vanstapel F, Van Hecke P,
Stalmans W. Demonstration of a glycogen/ glucose 1-phosphate cycle in
hepatocytes from fasted rats. Selective inactivation of phosphorylase by 2-
deoxy-2-fluoro-a-Dglucopyranosyl fluoride. J Biol Chem
1995;270(33):19351–19356.
298. Cadefau J, Bollen M, Stalmans W. Glucose induced glycogenesis in liver
involves the glucose -6-phosphate dependent dephosphorylation of glycogen
synthase. Biochem J 1997;322:745– 750.
299. Nguyen HT, Kim SM. Three compounds with potent _-glucosidase
inhibitory activity purified from Sea Cucumber Stichopus japonicas.
SPISE2009;112-122.
300. Ali H, Houghton PJ, Soumyanath A. α-Amylase inhibitory activity of some
Malaysian plants used to treat diabetes; with particular reference to
Phyllanthus amarus. J Ethnopharmacol 2006;107:449–455.
301. Adisakwattana S, Pudhom K, Yibchok-anun S. Influence of the methanolic
extract from Abutilon indicum leaves in normal and streptozotocin-induced
diabetic rats. African Journal of Biotechnology 2009;8:2011-2015.
302. Yoshikawa M, Morikawa T, Matsuda H, Tanabe G, Muraoka O. Absolute
Stereostructure of Potent α-Glucosidase Inhibitor, Salacinol, with Unique
Thiosugar Sulfonium Sulfate Inner Salt Structure from Salacia reticulate.
Bioorganic & Medicinal Chemistry 2002;10(5):1547–1554.
223
303. Subramanian R, Asmawi MZ, Sadikun A. In vitro α-glucosidase and α-
amylase enzyme inhibitory effects of Andrographis paniculata extract and
andrographolide. Acta Biochimica Polonica. 2008;55(2):391–398.
304. Apostolidis E, Kwon YII, Shetty K. Potential of cranberry-based herbal
synergies for diabetes and hypertension management. Asia Pac J Clin Nutr
2006;15:433–441.
305. Anis E, Anis I, Ahmed S, Mustafa G, Malik A, Afza N, Hai SM, Shahzad-
ul-hussan S, Choudhary MI. α-Glucosidase inhibitory constituents from
Cuscuta reflexa. Chem Pharm Bull 2002;50(1):112–114.
306. Pullela SV, Tiwari AK, Vanka UMS, Vummenthula A, Tatipaka HB, Dasari
KR Khan IA, Janaswamy MR.HPLC assisted chemobiological
standardization of α-glucosidase-I enzyme inhibitory constituents from Piper
longum Linn-An Indian medicinal plant. J Ethnopharmacol.
2006;108(3):445–449.
307. Georgetti SR, Casagrande R, Vicentini FTMC, Verri WA, Fonseca MJV.
Evaluation of the antioxidant activity of soybean extract by different in vitro
methods and investigation of this activity after its incorporation in topical
formulations. Eur J Pharm Biopharm 2006;64: 99–106.
308. Ojieh G C, Oluba OM, Erifeta GO, Eidangbe GO. Effect of aqueous root
extract of Treculia africana on haemoglobin glycosylation and plasma lipid
peroxidation in streptozotocin-induced diabetic rabbits. International Journal
of Plant Physiology and Biochemistry. 2009;1:5-8.
http://www.academicjournals.org/IJPPB
309. Rajasekaran S, Sivagnanam K, Subramanian S. Antioxidant effect of Aloe
vera gel extract in streptozotocin-induced diabetes in rats. Pharmacologica
Reports.2005; 57(1): 90-96.
310. Tembhurne SV, Sakarkar D M. Protective effect of Murraya koenigii (L)
leaves extract in streptozotocin induced diabetics rats involving possible
antioxidant mechanism. Journal of Medicinal Plants Research.2010;4:2418-
2423. http://www.academicjournals.org/JMPR
311. Pandhare R B, Sangameswaran B, Mohite P B, Khanage S G. Aqueous
extracts of the leaves of Sesbania sesban reduces development of diabetic
nephropathy in streptozotocininduced diabetic rat Bangladesh J Pharmacol
2010; 5: 103-106.
224
312. Padee P, Nualkaew S, Talubmook C, Sakuljaitrong S. Hypoglycemic effect
of a leaf extract of Pseuderanthemum palatiferum (Nees) Radlk. in normal
and streptozotocin-induced diabetic rats. J Ethnopharmacol. 2010;132:491–
496.
313. Ramudu SK, Korivi M, Kesireddy N, Lee LC, Cheng IS, Kuo CH,
Kesireddy SR. Nephro-Protective Effects of a Ginger Extract on Cytosolic
and Mitochondrial Enzymes against Streptozotocin (STZ)-Induced Diabetic
Complications in Rats. Chinese Journal of Physiology 2011;54(2):79-86.
314. Yassin MM, Ashour ARA, Nehad R. Elyazji NR. Alterations in body
weight, protein profile, nonprotein nitrogen constituents and kidney structure
in diabetic rats under glibenclamide treatment. Journal of the Islamic
University of Gaza, (Natural Sciences Series) 2004; 12(1): 37-54.)
315. Alnahdi HS. Effect of Rosmarinus Officinalis Extract on some Cardiac
Enzymes of Streptozotocin-induced Diabetic Rats Journal of Health
Sciences 2012, 2(4): 33-37. DOI: 10.5923/j.health.20120204.03)
316. Divi S, Bellamkonda R, Dasireddy SK.. Evaluation of antidiabetic and
antihyperlipedemic potential of aqueous extract of Moringa oleifera in
fructose fed insulin resistant and STZ induced diabetic Wistar rats: A
comparative study. Asian Journal of Pharmaceutical and Clinical Research.
2012;5(1):67-72.)
317. Herbst K J, Coltharp C, Amzel L M, Zhang J. Direct Activation of Epac by
Sulfonylurea is Isoform Selective. Chem Biol. 2011;18(2):243–251.
318. Chackrewarthy S, Thabrew MI, Weerasuriya MKB, Jayasekera S.
Evaluation of the hypoglycemic and hypolipidemic effects o an ethylacetate
fraction ofArtocarpus heterophyllus (jak) leaves in streptozotocin-induced
diabetic rats. Pharmacognosy magazine.2010;6:186-190.
319. MacDonald PE, Wheeler MB. Voltage-dependent K+ channels in pancreatic
beta cells: Role, regulation and potential as therapeutic targets. Diabetologia
2003;46(8):1046–1062.
320. Hossain MS, Sokeng S, Shoeb M, Hasan K, Mosihuzzaman M, Nahar N, Ali
L,Rokeya B. Hypoglycemic effect of Irvingia gabonensis(Aubry-Lacomate
Ex. Ororke), Baill in Type 2 Diabetic Long-Evans Rats. Dhaka Univ. J.
Pharm. Sci. 2012;11(1):19-24.
225
321. Reddy SR, Lavany T, Narasimhulu G, ReddyKS. Effect of Pimpinella
tirupatiensis on Oxidative Enzymes in STZ-induced Diabetic Rat Kidney
Iranian Journal of Pharmaceutical Research. 2012;11(1): 277-286.
Recommended